You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

discontinuation treatment TKI

Showing 1 - 25 of 1,950
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

Not yet recruiting
  • Tyrosine Kinase Inhibitors
  • Chronic Myeloid Leukemia
  • treatment of TKI in CML
  • Poitiers, France
    Chu Poitiers
Feb 21, 2023

TKI Discontinuation in CML Patients of China

Recruiting
  • Leukemia
  • +4 more
    • Shenzhen, Guangdong, China
      Shenzhen Second People's Hospital
    Mar 15, 2022

    Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia
    • Detroit, Michigan
    • +1 more
    May 3, 2022

    Withdrawal of Second-generation Tyrosine Kinase Inhibitors After

    Recruiting
    • MMR on 12 Month
    • Guangzhou, Guangdong, China
    • +1 more
    Apr 21, 2022

    Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)

    Active, not recruiting
    • Chronic Myeloid Leukemia
    • Freiburg, Baden-Württemberg, Germany
    • +14 more
    Nov 4, 2021

    Chronic Myeloid Leukemia Trial in Worldwide

    Recruiting
    • Chronic Myeloid Leukemia
      • Montréal, Quebec, Canada
      • +25 more
      Jul 25, 2022

      Innate T Cells and TKI Discontinuation

      Not yet recruiting
      • Chronic Myeloid Leukemia
      • Characteristics of innate T cells
      • (no location specified)
      Nov 25, 2020

      Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

      Active, not recruiting
      • Chronic Myeloid Leukemia
      • +2 more
      • Moscow, Russian Federation
        National Research Center for Hematology
      Oct 1, 2020

      Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

      Not yet recruiting
      • Chronic Myeloid Leukemia, BCR/ABL-Positive
        • Taipei, Taiwan
          National Taiwan University Hospital
        Jul 24, 2022

        NSCLC Trial (HS-10241+ Almonertinib, Pemetrexed + Cisplatin /Carboplatin)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • HS-10241+ Almonertinib
        • Pemetrexed + Cisplatin /Carboplatin
        • (no location specified)
        Oct 29, 2023

        CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

        Recruiting
        • CML
        • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
        • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
          FUNDALEU
        Jun 29, 2023

        The Life After Stopping Tyrosine Kinase Inhibitors Study

        Completed
        • Leukemia, Myeloid, Chronic
        • Imatinib (Stopping their TKI)
        • +3 more
        • San Francisco, California
        • +15 more
        Jan 3, 2023

        NSCLC Trial in Singapore (Afatinib 40 MG)

        Not yet recruiting
        • NSCLC
        • Afatinib 40 MG
        • Singapore, Singapore
          National University Hospital
        Sep 25, 2023

        Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)

        Recruiting
        • Acute Lymphoblastic Leukemia
        • Philadelphia Chromosome-Positive
        • Blinatumomab
        • +3 more
        • New York, New York
        • +1 more
        Nov 10, 2022

        NSCLC Trial in Worldwide (Repotrectinib, Crizotinib)

        Not yet recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Augusta, Georgia
        • +40 more
        Nov 29, 2023

        NSCLC Trial in Chendu (Almonertinib)

        Recruiting
        • Non-small Cell Lung Cancer
        • Chendu, Sichuan, China
          West China Hospital，Sichuan University
        Dec 14, 2022

        Renal Cell Carcinoma Trial in Worldwide (Nivolumab, Bempegaldesleukin, Axitinib)

        Active, not recruiting
        • Renal Cell Carcinoma
        • Nivolumab
        • +2 more
        • Springdale, Arkansas
        • +33 more
        Nov 22, 2022

        Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

        Not yet recruiting
        • Chronic Myeloid Leukemia
        • Treatment-free Remission
        • TFR(Treatment-Free Remission)
        • (no location specified)
        Jun 27, 2022

        Outcomes in Chronic Myeloid Leukaemia

        Completed
        • Chronic Myeloid Leukaemia
          • York, United Kingdom
            Haematological Malignancy Research Network
          Jun 7, 2023

          Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

          Recruiting
          • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
          • Chronic Phase Chronic Myelogenous Leukemia
          • Text Message-Based Navigation Intervention
          • Survey Administration
          • Philadelphia, Pennsylvania
            Sidney Kimmel Cancer Center at Thomas Jefferson University
          Apr 7, 2022

          Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

          Recruiting
          • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
          • Longmont, Colorado
          • +128 more
          Aug 1, 2022

          Colorectal Tumors Trial in Wuhan (Surufatinib)

          Recruiting
          • Colorectal Neoplasms
          • Chohort 1: Surufatinib
          • +2 more
          • Wuhan, Hubei, China
            Hubei Cancer Hospital
          Nov 5, 2022

          Metastatic Renal Cell Carcinoma, Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score Trial in France

          Not yet recruiting
          • Metastatic Renal Cell Carcinoma
          • Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score
          • Combination PD-1/PD-L1 ICI + VEGFR-TKI
          • Treatment pause
          • Bayonne, France
          • +24 more
          Aug 10, 2022

          Chronic Myeloid Leukemia Trial in Saint-Étienne (Pharmaceutical intervention)

          Recruiting
          • Chronic Myeloid Leukemia
          • Pharmaceutical intervention
          • Saint-Étienne, France
            CHU de Saint-Etienne
          Feb 24, 2022

          Chronic Myeloid Leukemia Trial in Worldwide (Stopping treatment with TKI)

          Completed
          • Chronic Myeloid Leukemia
          • Stopping treatment with TKI
          • Brno, Czechia
          • +49 more
          Oct 29, 2021